Opioid prescription and diabetes among Medicare beneficiaries
Authors' conclusion
Comorbidities and complications accounted for the higher odds of opioid prescriptions among those with diabetes.
Study context
- Population
- US Medicare beneficiaries aged ≥65 years continuously enrolled in Part A, B and D, 2017–2019
- Participants
- 709,374 beneficiaries
- Exposure
- Diabetes vs no diabetes
- Outcome
- Prevalence of any opioid prescription by diabetes status
Methodological detailsclaims data, logistic regression
- Claims data
- Logistic regression
Main finding
As reported in the abstract
Any opioid prescription
Diabetes vs No diabetesOdds ratio (CI)
Adjusted for sociodemographic characteristics
1.45(1.44–1.47)
- Further adjusted for comorbidities/complications
- OR 0.83 (CI 0.82–0.84)
Observational data: associations, not effects.
Further findings
Chronic opioid use
P < 0.001
Predictors of opioid prescription among persons with diabetes
- Hypertension, obesity, CVD, neuropathy, amputation, liver disease, COPD, cancer, osteoporosis, depression or alcohol/drug abuse: higher odds of opioid prescription vs without these conditions
- 20 %-140 %
Original publication
Opioid prescription and diabetes among Medicare beneficiaries. Diabetes Res Clin Pract. Published 4 January 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →